TheProfitWatch

MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.78 -0.17 (-9.56%) 0.01 (0.44%) 0.01 (0.44%) -0.03 (-1.54%) -0.11 (-6.18%) -0.08 (-4.74%) --- -0.11 (-6.18%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-17.8878
Diluted P/E:
-17.8878
RSI(14) 1m:
67.53
VWAP:
1.61
RVol:
0.5513

Events

Period Kind Movement Occurred At

Related News